BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 14732823)

  • 1. Hemoadsorption to improve organ recovery from brain-dead organ donors: a novel therapy for a novel indication?
    Venkataraman R; Song M; Lynas R; Kellum JA
    Blood Purif; 2004; 22(1):143-9. PubMed ID: 14732823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management to optimize organ procurement in brain dead donors.
    Mascia L; Mastromauro I; Viberti S; Vincenzi M; Zanello M
    Minerva Anestesiol; 2009 Mar; 75(3):125-33. PubMed ID: 18636057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant reduction of proinflammatory cytokines by treatment of the brain-dead donor.
    Kuecuek O; Mantouvalou L; Klemz R; Kotsch K; Volk HD; Jonas S; Wesslau C; Tullius S; Neuhaus P; Pratschke J
    Transplant Proc; 2005; 37(1):387-8. PubMed ID: 15808654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the cytokine response in liver donors at the time of organ procurement and association with allograft function after orthotopic transplantation.
    Palombo JD; Burke PA; Moldawer LL; Forse RA; Lewis WD; Jenkins RL
    J Am Coll Surg; 1994 Aug; 179(2):209-19. PubMed ID: 7519108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility study of cytokine removal by hemoadsorption in brain-dead humans.
    Kellum JA; Venkataraman R; Powner D; Elder M; Hergenroeder G; Carter M
    Crit Care Med; 2008 Jan; 36(1):268-72. PubMed ID: 18090355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic inflammation in the brain-dead organ donor.
    Barklin A
    Acta Anaesthesiol Scand; 2009 Apr; 53(4):425-35. PubMed ID: 19226294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation.
    Murugan R; Venkataraman R; Wahed AS; Elder M; Hergenroeder G; Carter M; Madden NJ; Powner D; Kellum JA;
    Crit Care Med; 2008 Jun; 36(6):1810-6. PubMed ID: 18496370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What can be learned from brain-death models?
    Pratschke J; Neuhaus P; Tullius SG
    Transpl Int; 2005 Jan; 18(1):15-21. PubMed ID: 15612978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation.
    Damman J; Nijboer WN; Schuurs TA; Leuvenink HG; Morariu AM; Tullius SG; van Goor H; Ploeg RJ; Seelen MA
    Nephrol Dial Transplant; 2011 Jul; 26(7):2345-54. PubMed ID: 21127132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Insulin Therapy using Hyper-insulinemic Normoglycemic Clamp on Inflammatory Response in Brain Dead Organ Donors.
    Aljiffry M; Hassanain M; Schricker T; Shaheen M; Nouh T; Lattermann R; Salman A; Wykes L; Metrakos P
    Exp Clin Endocrinol Diabetes; 2016 May; 124(5):318-23. PubMed ID: 27050068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oxidative stress and endotoxin on human serum albumin in brain-dead organ donors.
    Leber B; Stadlbauer V; Stiegler P; Stanzer S; Mayrhauser U; Koestenbauer S; Leopold B; Sereinigg M; Puntschart A; Stojakovic T; Tscheliessnigg KH; Oettl K
    Transl Res; 2012 Jun; 159(6):487-96. PubMed ID: 22633100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies.
    Novitzky D; Cooper DK; Rosendale JD; Kauffman HM
    Transplantation; 2006 Dec; 82(11):1396-401. PubMed ID: 17164704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of brain death on organ quality and transplant outcome.
    Floerchinger B; Oberhuber R; Tullius SG
    Transplant Rev (Orlando); 2012 Apr; 26(2):54-9. PubMed ID: 22459036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiorgan procurement increases systemic inflammation in brain dead donors.
    Auråen H; Mollnes TE; Bjørtuft Ø; Bakkan PA; Geiran O; Kongerud J; Fiane A; Holm AM
    Clin Transplant; 2013; 27(4):613-8. PubMed ID: 23803161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How important is the duration of the brain death period for the outcome in kidney transplantation?
    Nijboer WN; Moers C; Leuvenink HG; Ploeg RJ
    Transpl Int; 2011 Jan; 24(1):14-20. PubMed ID: 20819191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco smoke exposure in either the donor or recipient before transplantation accelerates cardiac allograft rejection, vascular inflammation, and graft loss.
    Khanna AK; Xu J; Uber PA; Burke AP; Baquet C; Mehra MR
    Circulation; 2009 Nov; 120(18):1814-21. PubMed ID: 19841304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting complement activation in brain-dead donors improves renal function after transplantation.
    Damman J; Hoeger S; Boneschansker L; Theruvath A; Waldherr R; Leuvenink HG; Ploeg RJ; Yard BA; Seelen MA
    Transpl Immunol; 2011 May; 24(4):233-7. PubMed ID: 21440065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial S100B levels before, during and after cerebral herniation.
    Undén J; Bellner J; Reinstrup P; Romner B
    Br J Neurosurg; 2004 Jun; 18(3):277-80. PubMed ID: 15327232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of brain death and non-heart-beating kidney donation on renal function and injury: an assessment in the isolated perfused rat kidney.
    van den Eijnden MM; Leuvenink HG; Ottens PJ; 't Hart NA; van Oeveren W; Morariu AM; van Goor H; Ploeg RJ
    Exp Clin Transplant; 2003 Dec; 1(2):85-95. PubMed ID: 15859914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and oxygen transport patterns after head trauma and brain death: implications for management of the organ donor.
    Belzberg H; Shoemaker WC; Wo CC; Nicholls TP; Dang AB; Zelman V; Gruen JP; Berne TV; Demetriades D
    J Trauma; 2007 Nov; 63(5):1032-42. PubMed ID: 17993948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.